Literature DB >> 18954553

Nitrite/nitrate and malondialdehyde levels in nasal polyp.

G Bugdayci1, M Kaymakci.   

Abstract

The aim of this study was to examine the pathophysiological role of NO (nitric oxide) and MDA (malondialdehyde) in tissue in patients with nasal polyposis. We measured nitrite/nitrate (Nitrite/Nitrate; NO2-/NO3-) and MDA in tissue and plasma of NP patients (n=20) and controls (n=20). MDA level expressed as the concentration of substances reacting to thiobarbituric acid and production of NO (concentration of nitrite/nitrate in plasma) by the Griess reaction were determined. The level of NO2- and NO3- in tissue are higher than that of the normal tissue (p<0.05). The level of MDA in tissue are higher than that of the normal tissue (p<0.05). The level of NO2- and NO3- in plasma of two groups are similar (p>0.05). The level of MDA in plasma is higher than that in the normal controls (p<0.05). The change in NO2-/NO3- and MDA levels of nasal polyp patients was demonstrated. Further studies are required concerning the significance of changes in lipid peroxidation and nitrite levels in pathogenesis of nasal polyp.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18954553

Source DB:  PubMed          Journal:  Cell Mol Biol (Noisy-le-grand)        ISSN: 0145-5680            Impact factor:   1.770


  3 in total

1.  Serum paraoxonase, arylesterase activity, and oxidative status in patients with nasal polyp.

Authors:  Wenwei Hao; Yongping Zhu; Li Meng; Changbao Ni; Jing Yang; Huifang Zhou
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-12-13       Impact factor: 2.503

2.  The glutathione-S-transferase gene polymorphisms (Gstt1, Gstm1, and Gstp1) in patients with non-allergic nasal polyposis.

Authors:  Cengiz Ozcan; Lülüfer Tamer; Nurcan Aras Ates; Kemal Görür
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-08-23       Impact factor: 2.503

3.  Evaluation of total oxidative stress parameters in patients with nasal polyps.

Authors:  F Bozkus; I San; T Ulas; I Iynen; Y Yesilova; Y Guler; N Aksoy
Journal:  Acta Otorhinolaryngol Ital       Date:  2013-08       Impact factor: 2.124

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.